-transparent.png){kind=logo}
Administration of orimeten (aminoglutethimide), for disseminated breast cancer in 38 postmenopausal females, in whom other treatment modalities had failed, proved effective in 39%. Patients who had failed on tamoxifen responded to orimeten. Such side-effects as skin rash, drowsiness and cardiovascular disturbances were not pronounced. Limiting toxicity was 6%.
Related Publications
T M Nadezhdina, and
G V Vyshinskaia, and
M R Lichinitser, and
L S Bassalyk, and
A M Garin
January 1988,
Sovetskaia meditsina,
T M Nadezhdina, and
G V Vyshinskaia, and
M R Lichinitser, and
L S Bassalyk, and
A M Garin
July 1983,
Ugeskrift for laeger,
T M Nadezhdina, and
G V Vyshinskaia, and
M R Lichinitser, and
L S Bassalyk, and
A M Garin
January 1987,
Nowotwory,
T M Nadezhdina, and
G V Vyshinskaia, and
M R Lichinitser, and
L S Bassalyk, and
A M Garin
December 1991,
Minerva ginecologica,
T M Nadezhdina, and
G V Vyshinskaia, and
M R Lichinitser, and
L S Bassalyk, and
A M Garin
November 1978,
Lancet (London, England),
T M Nadezhdina, and
G V Vyshinskaia, and
M R Lichinitser, and
L S Bassalyk, and
A M Garin
October 1985,
Tumori,
T M Nadezhdina, and
G V Vyshinskaia, and
M R Lichinitser, and
L S Bassalyk, and
A M Garin
October 1992,
Gan to kagaku ryoho. Cancer & chemotherapy,
T M Nadezhdina, and
G V Vyshinskaia, and
M R Lichinitser, and
L S Bassalyk, and
A M Garin
May 1978,
Klinicheskaia meditsina,
T M Nadezhdina, and
G V Vyshinskaia, and
M R Lichinitser, and
L S Bassalyk, and
A M Garin
September 1994,
Ginekologia polska,
T M Nadezhdina, and
G V Vyshinskaia, and
M R Lichinitser, and
L S Bassalyk, and
A M Garin
December 1985,
Wiener medizinische Wochenschrift (1946),
